Literature DB >> 26477021

"Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

F Montagnese1,2, S Wenninger3, B Schoser3.   

Abstract

Orbital myositis (OM) is a rare disease whose clinical heterogeneity and different treatment options represent a diagnostic and therapeutic challenge. We aim to review the state of knowledge on OM, also describing a cohort of patients diagnosed in our centre, to highlight some remarkable clinical features. A literature review was conducted in PubMed and Medline databases. The herein described cohort is composed of seven OM patients, diagnosed according to clinical, laboratory and neuroradiological features, whose clinical data were retrospectively analysed. OM is a non-infectious, inflammatory process primarily involving extraocular eye-muscles. It typically presents as an acute to sub-acute, painful ophthalmoplegia with signs of ocular inflammation, but atypical cases without pain or with a chronic progression have been described. The wide range of OM mimicking diseases make a prompt diagnosis challenging but orbit MRI provides valuable clues for differential diagnosis. Timely treatment is greatly important as OM promptly responds to steroids; nevertheless, partial recovery or relapses often occur. In refractory, recurrent or steroid-intolerant cases other therapeutic options (radiotherapy, immunosuppressants, immunoglobulins) can be adopted, but the most effective therapeutic management is yet to be established. In this review, we provide a detailed clinical description of OM, considering the main differential diagnoses and suggesting the most useful investigations. In light of the currently available data on therapy efficacy, we propose a therapeutic algorithm that may guide neurologists in OM patients' management.

Entities:  

Keywords:  Idiopathic orbital inflammatory syndromes (IOIS); Orbital myositis; Orbital pseudotumor; Therapy

Mesh:

Year:  2015        PMID: 26477021     DOI: 10.1007/s00415-015-7926-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  62 in total

Review 1.  Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.

Authors:  John H Lazarus
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

2.  The efficacy of radiotherapy in the treatment of orbital pseudotumor.

Authors:  Chance Matthiesen; Carl Bogardus; J Spencer Thompson; Bradley Farris; Lloyd Hildebrand; Byron Wilkes; Elizabeth Syzek; Ozer Algan; Salahuddin Ahmad; Terence Herman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-29       Impact factor: 7.038

3.  Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: The 2005 ASOPRS Foundation Lecture.

Authors:  Gerald J Harris
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Mar-Apr       Impact factor: 1.746

Review 4.  IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.

Authors:  Alan A McNab; Penny McKelvie
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 May-Jun       Impact factor: 1.746

Review 5.  Orbital inflammatory disease: Pictorial review and differential diagnosis.

Authors:  Michael N Pakdaman; Ali R Sepahdari; Sahar M Elkhamary
Journal:  World J Radiol       Date:  2014-04-28

6.  Clinical and echographic findings in idiopathic orbital myositis.

Authors:  R M Siatkowski; H Capó; S F Byrne; E K Gendron; J T Flynn; M Muñoz; W J Feuer
Journal:  Am J Ophthalmol       Date:  1994-09-15       Impact factor: 5.258

7.  Strong association between myotonic dystrophy type 2 and autoimmune diseases.

Authors:  A A Tieleman; A A den Broeder; A-E van de Logt; B G M van Engelen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-11       Impact factor: 10.154

8.  Idiopathic inflammatory orbital myositis presenting with vision loss.

Authors:  Jayanthi Peter; Nicholas H Andrew; Caroline Smith; Edwin Figueira; Dinesh Selva
Journal:  Orbit       Date:  2014-09-10

9.  Role of inferior rectus botulinum toxin injection in vertical strabismus resulting from orbital pathology.

Authors:  Howard J Bunting; Emma L M Dawson; John P Lee; Gillian G W Adams
Journal:  Strabismus       Date:  2013-09

10.  Two cases of orbital myositis as a rare feature of lyme borreliosis.

Authors:  Arnaud Sauer; Claude Speeg-Schatz; Yves Hansmann
Journal:  Case Rep Infect Dis       Date:  2011-07-28
View more
  8 in total

1.  Orbital myositis presenting with only unilateral orbital pain.

Authors:  Saori Utsunomiya; Daisuke Yamamoto; Tsuyoshi Uchiyama
Journal:  BMJ Case Rep       Date:  2017-06-03

2.  [Ocular myositis as a rare cause of vision loss].

Authors:  J D Rollnik; H Requadt
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

3.  Diagnostics and treatment of orbital myositis.

Authors:  Aida Pidro; Admira Dizdarević; Nina Jovanović; Alma Čerim; Emina Sačak; Ajla Pidro Miokovic
Journal:  Rom J Ophthalmol       Date:  2022 Apr-Jun

4.  Orbital myositis as an initial manifestation of Behcet's disease.

Authors:  Shinya Abe; Tatsuya Yunoki; Atsushi Hayashi
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-25

Review 5.  Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.

Authors:  M Marinò; I Ionni; G Lanzolla; A Sframeli; F Latrofa; R Rocchi; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-11-05       Impact factor: 5.467

Review 6.  Idiopathic Orbital Inflammation: Review of Literature and New Advances.

Authors:  Yağmur Seda Yeşiltaş; Ahmet Kaan Gündüz
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Apr-Jun

7.  Diagnostic dilemmas of mechanical restriction of the medial rectus: A case report.

Authors:  James A Gallogly; Farhoud Faraji; Mejd H Jumaily; John S Schneider; Joseph D Brunworth
Journal:  Allergy Rhinol (Providence)       Date:  2018-04-12

Review 8.  Differential diagnosis of acute ocular pain: Teleophthalmology during COVID-19 pandemic - A perspective.

Authors:  Somasheila I Murthy; Sujata Das; Parul Deshpande; Sushmita Kaushik; Tarjani Vivek Dave; Prachi Agashe; Nupur Goel; Anuj Soni
Journal:  Indian J Ophthalmol       Date:  2020-07       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.